Compound Detail

CHEMBL4864484

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CNc1ccc2c(cc1=O)[C@@H](NC(=O)N(C(C)C)C(C)C)CCc1cc(OC)c(OC)c(OC)c1-2

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4864484
Phase	Preclinical
Structure Type	MOL
InChI Key	SGRRISGRTRJVNE-FQEVSTJZSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

483.6

MW (Da)

4.60

ALogP

HBA

HBD

89.1

PSA (Å²)

0.60

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 7.38

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MCF7 CHEMBL387	IC50	7.38	7.38	42.0	1
LoVo CHEMBL614721	IC50	7.34	7.34	46.0	1
A549 CHEMBL392	IC50	7.13	7.13	74.0	1
BALB/3T3 CHEMBL613876	IC50	7.0	7.0	100.0	1
Unchecked CHEMBL612545	IC50	6.14	6.14	730.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MCF7	IC50	=	42.0	nM	7.38	Antiproliferative activity against human MCF-7 cells assessed as inhibition of p...	34116158
LoVo	IC50	=	46.0	nM	7.34	Antiproliferative activity against human LoVo cells assessed as inhibition of pr...	34116158
A549	IC50	=	74.0	nM	7.13	Antiproliferative activity against human A549 cells assessed as inhibition of pr...	34116158
BALB/3T3	IC50	=	100.0	nM	7.0	Antiproliferative activity against mouse BALB/3T3 cells assessed as inhibition o...	34116158
Unchecked	IC50	=	730.0	nM	6.14	Antiproliferative activity against human Lovo/DX cells assessed as inhibition of...	34116158

PubMed	DOI	Target Context	# Activities
34116158	10.1016/j.bmcl.2021.128197	Unchecked	2
34116158	10.1016/j.bmcl.2021.128197	LoVo	1
34116158	10.1016/j.bmcl.2021.128197	MCF7	1
34116158	10.1016/j.bmcl.2021.128197	A549	1
34116158	10.1016/j.bmcl.2021.128197	BALB/3T3	1

Data from ChEMBL 36 via Core Engine